Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.
about
Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments.Nanostructured self-assembly of inverted formin 2 (INF2) and F-actin-INF2 complexes revealed by atomic force microscopyActivity and architecture of pyroglutamate-modified amyloid-β (AβpE3-42) poresRole of the fast kinetics of pyroglutamate-modified amyloid-β oligomers in membrane binding and membrane permeability.Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region.Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD).The higher level of complexity of K-Ras4B activation at the membrane.Preferential interaction of the Alzheimer peptide Aβ-(1-42) with Omega-3-containing lipid bilayers: structure and interaction studies.Membrane-Accelerated Amyloid-β Aggregation and Formation of Cross-β Sheets.Common molecular mechanism of amyloid pore formation by Alzheimer's β-amyloid peptide and α-synuclein.Amyloid β Ion Channels in a Membrane Comprising Brain Total Lipid Extracts.Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β.The size-effect of gold nanoparticles and nanoclusters in the inhibition of amyloid-β fibrillation.Binding of protofibrillar Aβ trimers to lipid bilayer surface enhances Aβ structural stability and causes membrane thinning.Role of Bioinformatics in the Study of Ionic Channels.Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid β (Aβ) peptides in the monomer and protofibril states.No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.
P2860
Q30152727-B4F361EE-51E6-40E9-979C-2FAA80B5DF43Q33847676-031AC4DB-BA8C-4C4A-8892-647EA5E2F5A7Q33894606-C4E1D499-0630-4912-B224-7824543BD82EQ34434154-C61B05DB-A8E7-42D5-A577-3DAD421B9275Q35351594-B59D4939-890F-4DDE-A364-2F3044B29785Q35747721-B3060776-274B-4DFA-8E96-58622D3B7A7EQ36705290-1E5809F4-7125-4369-A7B0-4614C71BBA78Q40048000-AE4C1229-9AF4-4862-8BDD-D069DB2803B7Q41666582-EB2C5A7A-E57C-499B-9067-F227C122FB24Q42517974-F946A0E0-3A29-452E-A1F3-56F988E6B897Q46294211-3FBE771E-5AD5-4971-B860-A67EB3ECE1D5Q46423931-D05485B3-B067-4443-BA49-61E05B38397DQ47229854-E7AA4978-3A6E-4CB2-95BE-06552A02B70CQ47565192-9F9ACB88-86E0-480E-A487-4E1AB4B0C27EQ47600103-0A7D3857-D51C-422A-84E0-61A2BC6D1E5CQ47966515-E5E582E4-B65F-480F-8E06-8C83E1A4DA5DQ53698735-3011D2E9-A8FA-48C4-A8E6-848659AD0BE2
P2860
Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Disordered amyloidogenic pepti ...... mmon cyclic structural motifs.
@ast
Disordered amyloidogenic pepti ...... mmon cyclic structural motifs.
@en
Disordered amyloidogenic pepti ...... mmon cyclic structural motifs.
@nl
type
label
Disordered amyloidogenic pepti ...... mmon cyclic structural motifs.
@ast
Disordered amyloidogenic pepti ...... mmon cyclic structural motifs.
@en
Disordered amyloidogenic pepti ...... mmon cyclic structural motifs.
@nl
prefLabel
Disordered amyloidogenic pepti ...... mmon cyclic structural motifs.
@ast
Disordered amyloidogenic pepti ...... mmon cyclic structural motifs.
@en
Disordered amyloidogenic pepti ...... mmon cyclic structural motifs.
@nl
P2093
P2860
P50
P356
P1476
Disordered amyloidogenic pepti ...... mmon cyclic structural motifs.
@en
P2093
Bruce L Kagan
Hyunbum Jang
Ratnesh Lal
P2860
P304
P356
10.1039/C3CS60459D
P577
2014-10-01T00:00:00Z